Alatrofloxacin

Alatrofloxacin
Clinical data
AHFS/Drugs.com Micromedex Detailed Consumer Information
MedlinePlus a605016
Pregnancy
category
  • US: C (Risk not ruled out)
Routes of
administration
Intravenous
ATC code none
Legal status
Legal status
  • Withdrawn
Pharmacokinetic data
Bioavailability N/A
Protein binding 76% (trovafloxacin)
Metabolism Quickly hydrolyzed to trovafloxacin
Biological half-life 9 to 12 hours (trovafloxacin)
Excretion Fecal and renal (trovafloxacin)
Identifiers
CAS Number 146961-76-4 N
ChemSpider 21243647 N
UNII 7QVV6I50DT YesY
ChEMBL CHEMBL1201197 N
Chemical and physical data
Formula C26H25F3N6O5
Molar mass 558.509 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Alatrofloxacin (Trovan IV) is a fluoroquinolone antibiotic developed by Pfizer, delivered as a mesylate salt.[1]

Trovafloxacin and alatrofloxacin were both withdrawn from the U.S. market in 2001.

See also

References

  1. "Center for Drug Evaluation and Research – Application Number: 020759/020760 – Chemistry Review(s)" (PDF). Food and Drug Administration. Retrieved 29 August 2014.


This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.